Skip to main content
Advertisement
  • Loading metrics

PLoS Medicine Issue Image | Vol. 17(1) October 2020

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Human papillomaviruses (HPV) cause several serious and life-threatening diseases, with cervical cancer having received the most attention. In recent years, effective vaccines protecting against the most high-risk HPV types have become available and are now provided to populations in many high-income countries. However, in low- and middle-income countries HPV vaccines are much less widely available at present, and in these settings population screening for cervical cancer and its precursors may also be absent.

In this month’s Editorial, Karin Sundström and Miriam Elfström discuss plans to roll-out HPV vaccines for prevention of cervical cancer and other diseases more generally, and consider the longer-term prospects for cervical cancer elimination.

Image Credit: Hey Paul Studios, Flickr

thumbnail
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Human papillomaviruses (HPV) cause several serious and life-threatening diseases, with cervical cancer having received the most attention. In recent years, effective vaccines protecting against the most high-risk HPV types have become available and are now provided to populations in many high-income countries. However, in low- and middle-income countries HPV vaccines are much less widely available at present, and in these settings population screening for cervical cancer and its precursors may also be absent.

In this month’s Editorial, Karin Sundström and Miriam Elfström discuss plans to roll-out HPV vaccines for prevention of cervical cancer and other diseases more generally, and consider the longer-term prospects for cervical cancer elimination.

Image Credit: Hey Paul Studios, Flickr

https://doi.org/10.1371/image.pmed.v17.i01.g001